April 21, 2014 7:09 AM ET

Biotechnology

Company Overview of Elusys Therapeutics, Inc.

Executive Profile

Ronald Taylor Ph.D.

Member of Scientific Advisory Board, Elusys Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Ronald Taylor, Ph.D. serves as Member of Scientific Advisory Board of EluSys Therapeutics, Inc. Dr. Taylor serves as Professor of Biochemistry at the University of Virginia and the primary inventor of the Heteropolymer-mediated system to remove blood-borne pathogens. He has been actively engaged in research studies in the field of immunology, complement fixation, and autoimmune diseases for over 20 years. Dr. Taylor received his BS in Chemistry from City College and ...

Corporate Headquarters

25 Riverside Drive
Pine Brook, New Jersey 07058

United States

Phone: 973-808-0222
Fax: 973-808-0322

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Princeton University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elusys Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.